MedPath

Comparing 4L Golytely to 2L Golytely With 15mg Bisacodyl Regimens for Inpatient Colonic Preparation

Not Applicable
Withdrawn
Conditions
Colonoscopy
Interventions
Drug: 2L Golytely/bisacodyl
Drug: Standard Bowel Prep
Registration Number
NCT01452737
Lead Sponsor
University of British Columbia
Brief Summary

The investigators wish to compare the efficacy and patient tolerability of a preparation consisting of 2L Golytely (PEG + electrolytes) plus 15mg of bisacodyl vs the standard preparation of 4L Golytely. The investigators hypothesize that 2L Golytely with 15mg bisacodyl will show similar bowel cleansing efficacy while offering better tolerability.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Inpatients undergoing colonoscopy
  • Age 19 or over
Exclusion Criteria
  • Unable to provide informed consent
  • Patients with constipation
  • Patients with suspected bowel obstruction or severe inflammatory bowel disease
  • Same-day colonoscopy
  • Intensive/critical care patient
  • History of colorectal resection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2L Golytely/15mg bisacodyl2L Golytely/bisacodylSubjects will be asked to take 2L Golytely + 15mg bisacodyl for bowel prep the day before colonoscopy.
Standard bowel prepStandard Bowel PrepSubject will receive standard bowel prep (4L Golytely) prior to colonoscopy.
Primary Outcome Measures
NameTimeMethod
Difference in Boston Bowel Preparation Scale & Ottawa Bowel Preparation Scale between the two groups30min

These are established rating scales to evaluate the quality of bowel prep. The ratings will be compared between the two groups.

Secondary Outcome Measures
NameTimeMethod
Difference in the absolute number/percentage of participants in the two groups who find the bowel prep experience easy, acceptable, difficult, very difficult, or unable to complete.20hours

Participants will be asked to rate their bowel prep experience (based on ease of use) on a Likert scale. The number of participants in each level will subsequently be quantified (n, %) and compared between the two groups.

Difference in the number of participants who develop distress symptoms from bowel prep (and the type) between the two groups20hours

Number of participants who develop distress symptoms from bowel prep, and the type of distress symptoms will be compared between the two groups

Trial Locations

Locations (1)

St. Paul's Hospital

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath